188 related articles for article (PubMed ID: 31943295)
1. Novel 3-aryl-5-substituted-coumarin analogues: Synthesis and bioactivity profile.
Kavetsou E; Katopodi A; Argyri L; Chainoglou E; Pontiki E; Hadjipavlou-Litina D; Chroni A; Detsi A
Drug Dev Res; 2020 Jun; 81(4):456-469. PubMed ID: 31943295
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Bioactivity, Pharmacokinetic and Biomimetic Properties of Multi-Substituted Coumarin Derivatives.
Katopodi A; Tsotsou E; Iliou T; Deligiannidou GE; Pontiki E; Kontogiorgis C; Tsopelas F; Detsi A
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641543
[TBL] [Abstract][Full Text] [Related]
3. Structural modifications of coumarin derivatives: Determination of antioxidant and lipoxygenase (LOX) inhibitory activity.
Roussaki M; Zelianaios K; Kavetsou E; Hamilakis S; Hadjipavlou-Litina D; Kontogiorgis C; Liargkova T; Detsi A
Bioorg Med Chem; 2014 Dec; 22(23):6586-6594. PubMed ID: 25456384
[TBL] [Abstract][Full Text] [Related]
4. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity.
Roussaki M; Kontogiorgis CA; Hadjipavlou-Litina D; Hamilakis S; Detsi A
Bioorg Med Chem Lett; 2010 Jul; 20(13):3889-92. PubMed ID: 20627725
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of hydroxylated 3-phenylcoumarins as antioxidants and antiproliferative agents.
Yang J; Liu GY; Dai F; Cao XY; Kang YF; Hu LM; Tang JJ; Li XZ; Li Y; Jin XL; Zhou B
Bioorg Med Chem Lett; 2011 Nov; 21(21):6420-5. PubMed ID: 21920747
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors.
Iranshahi M; Jabbari A; Orafaie A; Mehri R; Zeraatkar S; Ahmadi T; Alimardani M; Sadeghian H
Eur J Med Chem; 2012 Nov; 57():134-42. PubMed ID: 23047230
[TBL] [Abstract][Full Text] [Related]
7. Novel cinnamic acid derivatives as antioxidant and anticancer agents: design, synthesis and modeling studies.
Pontiki E; Hadjipavlou-Litina D; Litinas K; Geromichalos G
Molecules; 2014 Jul; 19(7):9655-74. PubMed ID: 25004073
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives.
Srivastava P; Vyas VK; Variya B; Patel P; Qureshi G; Ghate M
Bioorg Chem; 2016 Aug; 67():130-8. PubMed ID: 27376460
[TBL] [Abstract][Full Text] [Related]
9. Exploring the 2'-Hydroxy-Chalcone Framework for the Development of Dual Antioxidant and Soybean Lipoxygenase Inhibitory Agents.
Kostopoulou I; Tzani A; Polyzos NI; Karadendrou MA; Kritsi E; Pontiki E; Liargkova T; Hadjipavlou-Litina D; Zoumpoulakis P; Detsi A
Molecules; 2021 May; 26(9):. PubMed ID: 34066803
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL
Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological activity evaluation and molecular docking studies of novel coumarin substituted thiazolyl-3-aryl-pyrazole-4-carbaldehydes.
Vaarla K; Kesharwani RK; Santosh K; Vedula RR; Kotamraju S; Toopurani MK
Bioorg Med Chem Lett; 2015 Dec; 25(24):5797-803. PubMed ID: 26542964
[TBL] [Abstract][Full Text] [Related]
14. Coumarin-based bioactive compounds: facile synthesis and biological evaluation of coumarin-fused 1,4-thiazepines.
Khoobi M; Foroumadi A; Emami S; Safavi M; Dehghan G; Alizadeh BH; Ramazani A; Ardestani SK; Shafiee A
Chem Biol Drug Des; 2011 Oct; 78(4):580-6. PubMed ID: 21740531
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
Melagraki G; Afantitis A; Igglessi-Markopoulou O; Detsi A; Koufaki M; Kontogiorgis C; Hadjipavlou-Litina DJ
Eur J Med Chem; 2009 Jul; 44(7):3020-6. PubMed ID: 19232783
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
[TBL] [Abstract][Full Text] [Related]
17. Investigating the Anti-tumor and Apoptosis-inducing Effects of Coumarin Derivatives as Potent 15-Lipoxygenase Inhibitors on PC-3 Prostate Cancer Cells.
Maleki F; Sadeghian H; Bahrami AR; Goftari SN; Matin MM
Anticancer Agents Med Chem; 2023; 23(15):1722-1730. PubMed ID: 37171011
[TBL] [Abstract][Full Text] [Related]
18. O-prenylated 3-carboxycoumarins as a novel class of 15-LOX-1 inhibitors.
Jabbari A; Mousavian M; Seyedi SM; Bakavoli M; Sadeghian H
PLoS One; 2017; 12(2):e0171789. PubMed ID: 28182779
[TBL] [Abstract][Full Text] [Related]
19. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS
Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711
[TBL] [Abstract][Full Text] [Related]
20. Benzazole Substituted Iminocoumarins as Potential Antioxidants with Antiproliferative Activity.
Perin N; Cindrić M; Vervaeke P; Liekens S; Mašek T; Starčević K; Hranjec M
Med Chem; 2021; 17(1):13-20. PubMed ID: 31849290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
